Darwin Global Management, Ltd. Verona Pharma PLC Transaction History
Darwin Global Management, Ltd.
- $1.44 Billion
- Q1 2025
A detailed history of Darwin Global Management, Ltd. transactions in Verona Pharma PLC stock. As of the latest transaction made, Darwin Global Management, Ltd. holds 3,923,204 shares of VRNA stock, worth $414 Million. This represents 17.31% of its overall portfolio holdings.
Number of Shares
3,923,204
Previous 810,449
384.08%
Holding current value
$414 Million
Previous $37.6 Million
561.81%
% of portfolio
17.31%
Previous 3.56%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
296Shares Held
73.5MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$692 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$581 Million0.2% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$364 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$305 Million3.9% of portfolio
-
Rtw Investments, LP New York, NY2.85MShares$300 Million2.96% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.42B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...